Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Total Current Liabilities: 2011-2025

Historic Total Current Liabilities for Abeona Therapeutics (ABEO) over the last 15 years, with Sep 2025 value amounting to $22.2 million.

  • Abeona Therapeutics' Total Current Liabilities rose 20.40% to $22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.2 million, marking a year-over-year increase of 20.40%. This contributed to the annual value of $16.6 million for FY2024, which is 23.58% up from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Total Current Liabilities is $22.2 million, which was down 35.74% from $34.5 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Total Current Liabilities ranged from a high of $41.9 million in Q2 2021 and a low of $7.4 million during Q1 2023.
  • Moreover, its 3-year median value for Total Current Liabilities was $16.6 million (2024), whereas its average is $16.1 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 69.79% in 2022, then skyrocketed by 119.00% in 2024.
  • Abeona Therapeutics' Total Current Liabilities (Quarterly) stood at $16.6 million in 2021, then crashed by 53.20% to $7.8 million in 2022, then skyrocketed by 72.54% to $13.4 million in 2023, then climbed by 23.58% to $16.6 million in 2024, then rose by 20.40% to $22.2 million in 2025.
  • Its Total Current Liabilities stands at $22.2 million for Q3 2025, versus $34.5 million for Q2 2025 and $18.0 million for Q1 2025.